Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

STMicroelectronics, InvenSense Settle Pending Patent Litigation

RELATED NEWS
Trade STM now with 

STMicroelectronics NV (STM: Quote) and InvenSense, Inc. (INVN: Quote) said Monday that they have settled all pending proceedings between them and have entered into a patent cross license agreement.

The two companies had instituted various proceedings beginning in May 2012 in the United States District Court for the Northern District of California, the United States District Court for the Eastern District of Texas, the United States Patent and Trademark Office and with the United States International Trade Commission. This settlement and patent cross license resolves all such actions.

Under terms of the settlement, neither ST nor InvenSense has made any admission of liability with respect to such proceedings. Other terms between the parties are confidential.

Click here to receive FREE breaking news email alerts for STMicroelectronics NV and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.